Latest News about CMPS

Recent news which mentions CMPS

< Previous 1 2 3 4 5 6 7 8 9

...

The Promise Of Psilocybin When It Comes To Mental Health, And How COMPASS Pathways (NASDAQ: CMPS) Is Advancing It

October 11, 2023

Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More

October 06, 2023

COMPASS Pathways Is Accelerating Patient Access To Evidence-Based Innovation In Mental Health Care

October 05, 2023

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More

October 02, 2023

Don’t Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher

September 27, 2023

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More

September 26, 2023

Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More

September 18, 2023

One Year Into Kabir Nath's Leadership, Compass Pathways' (NASDAQ: CMPS) Phase 3 Trial For Innovative Treatment Resistant Depression Progressing

September 18, 2023

Swedish Foundation Supports Mental Health Innovation With New €3M Psychedelic Science Initiative

September 13, 2023

NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years

September 12, 2023

What's Spurring The Growth Of The Psychedelics Market – And How One Company Is Helping As Part Of The Vanguard In This Emerging Field

September 12, 2023

Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More

September 11, 2023

Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression

September 06, 2023

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More

September 05, 2023

Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More

August 28, 2023

3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street

August 26, 2023

The Latest Analyst Ratings for Compass Pathways

August 22, 2023

Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports

August 21, 2023

COMPASS' Securities Purchase Agreement Is Big News

August 18, 2023

Up To $285M In Financing: COMPASS Pathways' Private Placement Backed By 'Select Group' Of Investors

August 16, 2023

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More

August 14, 2023

Atai's Q2 2023 Plus Clinical Data On Ibogaine-Opioid Study, Pipeline's Psilocybin, DMT, Ketamine & MDMA

August 10, 2023

Compass Pathways Plc (CMPS) Q2 2023 Earnings Call Transcript

August 04, 2023

COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business'

August 03, 2023

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More

August 03, 2023

Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial

July 28, 2023

This Unexpected Development Is Yet Another Green Flag for Compass Pathways Stock

July 28, 2023

Compass' Psilocybin Therapy Proves Helpful In Treating Anorexia: Clinical Trial Shows

July 25, 2023

Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More

July 24, 2023

AMA Issues Details On First Psychedelics Therapy CPT Code – Thanks To These Psychedelic-Focused Mental Healthcare Companies

July 24, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.